The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 975.00
Bid: 970.00
Ask: 975.00
Change: 0.00 (0.00%)
Spread: 5.00 (0.515%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 975.00
CVSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

31 Jul 2017 07:00

RNS Number : 4974M
CVS Group plc
31 July 2017
 

 

31 July 2017

 

CVS Group plc ("CVS" or the "Group")

 

Trading Update

 

CVS, the UK's leading provider of integrated veterinary services, is pleased to provide the following trading update in respect of the financial year ended 30 June 2017. All comparative data relates to the year ended 30 June 2016. The Group expects to announce its full year results on Friday 29 September 2017.

 

Revenue and adjusted EBITDA for the recently ended financial year are anticipated to be in line with market expectations.

 

Group revenue for the year showed total like-for-like growth of 6.3%. This figure reflects particularly strong growth for Animed Direct during the second half of the year as the business responded to management initiatives. Growth in the Veterinary Practices Division has been sustained at more normal levels.

 

The high pace of acquisitions continued in the year to 30 June 2017 with a total of 62 surgeries being acquired. £47.4m (including net debt acquired) was paid for these acquisitions.

 

42 surgeries were acquired in the second half of the year:

 

Practice name

No. of sites

Main locations

Business

Zuid-West Friesland BV

2

Lemmer, Emmelord, (The Netherlands)

Small animal, large animal & equine

Bell Equine Veterinary Clinic

1

Mereworth

Equine

Valley Veterinary Group

2

Kilmarnock

Small animal

Pennine Vets

2

Bolton, Bury

Small animal

Ambivet Veterinary Group

5

Aspley, Heanor, Ilkeston Ripley Woollaton,

Small animal

Willow Veterinary Clinic Norwich

1

Norwich, Norfolk

Small animal

Champion Vet

4

Glasgow, Paisley, East Kilbride and Grangemouth

Small animal

Eagle Veterinary Group

1

Halesworth

Small animal

Animed Veterinary Centre

2

Whitstable, Beltinge

Small animal

Phoenix Vets

2

Camberley, Sandhurst

Small animal

All Creatures Veterinary Health Centre

1

Limavady (Northern Ireland)

Small animal

Shannon Lodge Veterinary Practice

1

Sutton-in-Ashfield

Small animal

Medina Veterinary Group

3

Isle of Wight

Small animal

Severn Edge Veterinary Group

12

Shropshire

Small animal, large animal & equine

Radis Creations BV

3

Zwolle, Henelgo, Amersfoort (Netherlands)

Small animal

 

 

Of particular note in the second half were the acquisitions in the Netherlands of Zuid-West Friesland BV and Radis Creations BV bringing the number of surgeries the Group owns in the Netherlands to nine.

 

In the UK, the acquisition of Severn Edge Veterinary Group gives CVS a strong presence in Shropshire in small animal and large animal, and together with the acquisition of Bell Equine, expands our equine capability significantly.

 

The Group now operates a total of 422 veterinary surgeries (413 in the UK and 9 in the Netherlands), an on-line dispensary, four diagnostic laboratories and seven pet crematoria.

 

CVS continues to see a significant number of acquisition opportunities and is able to focus on those that offer the best potential for the Group. Following this period of high activity, which enabled much of the equity capital raised in December to be deployed, in order to maintain financial flexibility the Group increased its total borrowing facilities to £152.5m (from £115.0m) shortly after the year end. The increased margin payable on the expanded facility is expected to add c.£0.6m p.a. to finance. Net borrowings at 30th June 2017 were £100m.

 

The Board anticipates further like-for-like growth in line with normal levels and the impact of the acquisitions made during the year ended 30 June 2017 will add significantly to the profitability of the Group. Further acquisitions and general progress across all of the Group's divisions are expected.

 

This announcement contains inside information.

 

For further enquiries please contact:

 

CVS Group plc

Simon Innes, Chief Executive

Nick Perrin, Finance Director

 

Tel: 01379 644 288

 

N+1 Singer (Nominated Adviser & Broker)

Aubrey Powell

Liz Yong

 

Tel: 020 7496 3000

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTZMGZNVRFGNZM
Date   Source Headline
30th Nov 20184:53 pmRNSHolding(s) in Company
29th Nov 20181:48 pmRNSResult of AGM
29th Nov 20187:00 amRNSAnnual General Meeting Trading Update
14th Nov 201811:48 amRNSHolding(s) in Company
12th Nov 20183:56 pmRNSHolding(s) in Company
12th Nov 20183:50 pmRNSHolding(s) in Company
6th Nov 20185:11 pmRNSPosting of Annual Report and Notice of AGM
5th Nov 20188:05 amRNSExercise of Options, Directors' Dealing and TVR
31st Oct 20185:32 pmRNSTotal Voting Rights
24th Oct 201810:43 amRNSHolding(s) in Company
16th Oct 201812:51 pmRNSLong Term Incentive Plan Awards
15th Oct 20187:00 amRNSHolding(s) in Company
4th Oct 20187:00 amRNSExercise of Options and Total Voting Rights
27th Sep 20187:00 amRNSPreliminary Results
21st Sep 20184:21 pmRNSHolding(s) in Company
21st Sep 20184:21 pmRNSHolding(s) in Company
24th Aug 201812:22 pmRNSHolding(s) in Company
23rd Aug 20182:56 pmRNSHolding(s) in Company
21st Aug 20184:22 pmRNSHolding(s) in Company
21st Aug 20183:32 pmRNSHolding(s) in Company
2nd Aug 20187:00 amRNSTrading Statement & Board Update
31st Jul 20185:45 pmRNSExercise of Options and Total Voting Rights
20th Jul 20187:00 amRNSBoard Changes and Notice of Trading Update
10th Jul 201810:35 amRNSHolding(s) in Company
6th Jul 20185:11 pmRNSHolding(s) in Company
2nd Jul 20184:51 pmRNSDirector/PDMR Shareholding
2nd Jul 20184:46 pmRNSTotal Voting Rights
2nd Jul 20183:05 pmRNSHolding(s) in Company
19th Jun 20187:00 amRNSBlock listing Interim Review
7th Jun 20184:18 pmRNSHolding(s) in Company
31st May 20183:40 pmRNSExercise of Options and Total Voting Rights
22nd May 20182:47 pmRNSHolding(s) in Company
18th May 20184:33 pmRNSHolding(s) in Company
10th May 20182:33 pmRNSHolding(s) in Company
4th May 20185:31 pmRNSHolding(s) in Company
30th Apr 20184:47 pmRNSTotal Voting Rights
24th Apr 20183:13 pmRNSHolding(s) in Company
23rd Apr 20185:55 pmRNSHolding(s) in Company
10th Apr 20182:26 pmRNSExercise of Options & TVR
4th Apr 201812:05 pmRNSDirector/PDMR and PCA Shareholding
3rd Apr 20188:20 amRNSHolding(s) in Company
29th Mar 20187:00 amRNSTotal Voting Rights
28th Mar 20184:42 pmRNSExercise of Options, Director/PCA Dealing & TVR
20th Mar 20183:06 pmRNSExercise of Options, Directors' dealings and TVR
1st Mar 20183:30 pmRNSTotal Voting Rights
21st Feb 20184:17 pmRNSHolding(s) in Company
16th Feb 20185:36 pmRNSResult of Placing
16th Feb 201812:45 pmRNSPlacing Update
16th Feb 201811:05 amRNSClose of Accelerated Bookbuild
16th Feb 20187:01 amRNSProposed Accelerated Bookbuild

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.